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Abstract
Background: Climate change is likely to be one of the most important threats to public health in the coming years. Yet
despite the large number of papers considering the health impact of climate change, few have considered what public
health interventions may be of most value in reducing the disease burden. We aimed to evaluate the effectiveness of public
health interventions to reduce the disease burden of high priority climate sensitive diseases.
Methods and Findings: For each disease, we performed a systematic search with no restriction on date or language of
publication on Medline, Web of Knowledge, Cochrane CENTRAL and SCOPUS up to December 2010 to identify systematic
reviews of public health interventions. We retrieved some 3176 records of which 85 full papers were assessed and 33
included in the review. The included papers investigated the effect of public health interventions on various outcome
measures. All interventions were GRADE assessed to determine the strength of evidence. In addition we developed a
systematic review quality score. The interventions included environmental interventions to control vectors, chemoprophy-
laxis, immunization, household and community water treatment, greening cities and community advice. For most reviews,
GRADE showed low quality of evidence because of poor study design and high heterogeneity. Also for some key areas such
as floods, droughts and other weather extremes, there are no adequate systematic reviews of potential public health
interventions.
Conclusion: In conclusion, we found the evidence base to be mostly weak for environmental interventions that could have
the most value in a warmer world. Nevertheless, such interventions should not be dismissed. Future research on public
health interventions for climate change adaptation needs to be concerned about quality in study design and should address
the gap for floods, droughts and other extreme weather events that pose a risk to health.
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Introduction
There is consensus that climate change is affecting human
health [1]. Although the exact health impacts of climate change
are still being debated these are likely to include heat stress,
increased risk of vector-borne, waterborne and food-borne
diseases. In addition, the increased frequency of extreme weather
events such as drought, flooding or hurricanes will also have a
range of public health impacts. Nevertheless, linkages between
public health and climate change are complex and interact with
other factors. This review is not a systematic evaluation of climate
sensitive diseases; it is rather focusing on the likely adverse health
impacts of climate change.
Arthropod-borne diseases are infections spread by insect
(mosquitoes and sandflies) or arachnid (ticks) vectors [2]. Major
shifts in the epidemiology of several vector-borne diseases and
appearances on new continents have been predicted as a result of
climate change [3,4,5,6,7]. Climate change is likely to increase the
burden of West Nile fever, dengue, Chikungunya fever, malaria,
leishmaniasis, tick-borne encephalitis, Lyme borreliosis, Crimean-
Congo haemorrhagic fever, spotted fever rickettsioses, Yellow
fever and Rift Valley fever [2,7,8,9,10].
Waterborne diseases are also likely to be influenced by climate
change. The importance of climate as a driver of disease risk is
derived from observations that waterborne disease outbreaks are
often preceded by heavy rainfall [11,12,13,14]. This link is likely to
be most obvious for inadequately treated water or small rural
supplies [15,16,17,18,19]. Several authors have pointed out links
between cholera and climate variables especially higher temper-
ature and rainfall [20,21,22,23], flooding [24,25] and major
climatic cycles such as El Nino [26,27]. Risk from non-cholera
vibrios, especially V. vulnificus and V. parahaemolyticus in marine
waters, is increasing with warmer sea temperatures and higher
trophic state index [28,29,30]. Cyanobacteria are present in
drinking and recreational waters and most reported human cases
were associated with observable cyanobacterial blooms [31]. The
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impact of droughts on health through reduced access to water in
affluent countries is not clear, but effects in resource poor countries
are likely to be dramatic [32,33].
Extreme weather events pose particular challenges to popula-
tions. The frequency and intensity of extreme weather events is
predicted to rise as a result of climate variability [8]. The effects of
disasters such as floods, extreme droughts, storms and hurricanes
on human health seem to be mostly indirect (mediated through
vector and waterborne diseases), nevertheless, acute injuries,
fatalities and mental health illnesses are also significant public
health outcomes but their management and prevention (disaster
preparedness and response planning) are beyond the scope of this
study. The problems of heat stress and heat stress-related mortality
are considered an area of major direct impact because of the
severity of the outcome (death) and increased political sensitivity
[8,34]. The intense 2003 European heat wave caused the death of
22,000–35,000 mainly elderly persons [34,35].
There are other diseases that are likely to be exacerbated in a
warmer world including food-borne and respiratory diseases. It
has been shown that reported cases of salmonellosis peak in the hot
summer months and that this association was observed at
temperatures greater than 7.5uC [36]. We consider the effect of
climate change on food-borne diseases to be minimal providing
appropriate food handling and storage procedures and improved
food hygiene as previously reported by Lake and colleagues [37].
Respiratory diseases are mainly linked to air quality. Concentra-
tions of air pollutants (mainly ozone and particulate matter) would
increase with greenhouse gas emissions and higher temperatures
[38]. Because the main driver of respiratory disease is air pollution
itself rather than climate change, it will not be included in our high
priority climate sensitive diseases. In addition, the main interven-
tion for respiratory diseases is emission reduction, which is beyond
the scope of this study.
Despite substantial peer-reviewed and gray literature investi-
gating potential health impacts of climate change, less attention
has been paid to adaptation options. While implementation of
effective control interventions is the only way to reduce the disease
burden of climate change, evaluation of the effectiveness of public
health interventions is lacking. As the World Health Organization
(WHO) stated ‘‘There is a lack of targeted, systematic reviews to
identify and assess the effectiveness of interventions to control key
climate-sensitive health risks, e.g. for the control of vector-borne
diseases or heat health action plans’’ [9]. Our objective is to
address this gap and systematically review existing systematic
reviews on the effectiveness of public health interventions to
reduce the disease burden of climate change.
Methods
Search methodology and inclusion criteria
Included studies were systematic reviews (defined as reviews
with a specified methodology that included searches of at least 2
databases or one database plus references from at least one earlier
systematic review) of any public health intervention for these
climate sensitive health risks (West Nile fever, dengue, Chikungu-
nya fever, malaria, leishmaniasis, tick-borne encephalitis, Lyme
borreliosis, Crimean-Congo haemorrhagic fever, spotted fever
rickettsioses, Yellow fever, Rift Valley fever, cholera, waterborne
diseases, floods, droughts cyanobacteria, and heat stress) with any
health related outcome measures (disease incidence/prevalence/
risk, clinical manifestation, entomological indices for mosquito-
borne diseases). Studies presenting primary data for interventions
or assessing efficiency of therapeutic methods were excluded unless
such interventions could be carried out by lay people. Where
systematic reviews had been updated, only the newest version was
included.
Ovid MEDLINE, ISI Web of Knowledge, Cochrane CEN-
TRAL and SCOPUS databases were searched with no restriction
on year or language of publication up to December 2010. A broad
search strategy was used to improve sensitivity and to include any
type of public health intervention. For each disease/issue, specific
key words and/or MeSH terms were used (Table S1) and the
search was combined with ‘‘systematic review’’ or ‘‘meta-analysis’’.
Reference lists from obtained articles were screened for additional
relevant reviews. No protocol has been published for this
systematic review.
Titles, abstracts and full texts were assessed independently for
inclusion by two reviewers. Data extraction was performed in
duplicate using a standardised form. Recorded information
included main outcome measure, number of included studies,
and effectiveness in terms of Relative Risk where provided, or Risk
Ratio, odds ratio or biological indices where necessary.
Assessment of the quality of evidence using GRADE
For each systematic review, the quality of the evidence was
assessed using the GRADE method (an acronym for Grading of
Recommendations: Assessment, Development and Evaluation
(http://www.gradeworkinggroup.org/)). GRADE provides guid-
ance for rating quality of evidence and grading strength of
recommendations in health care and is widely used by interna-
tional organisations including WHO [38,39]. GRADE assesses the
quality of a body of evidence based on 5 criteria: risk of bias,
imprecision, inconsistency, indirectness of evidence and publica-
tion bias [40]. Within this review each domain was assessed based
on the following scale: ‘‘no’’ (no risk of bias or imprecision or
inconsistency or publication bias, depending on the domain) (score
0), ‘‘serious’’ (serious risk of bias etc.) (score 21) or ‘‘very serious’’
(very serious risk of bias or publication bias etc.) (score 22). The
basis of assessment was
N Risk of bias – Allocation concealment, lack of blinding and
incomplete accounting for fate of participants. Serious risk of
bias was indicated by poor allocation concealment, blinding or
follow-up, or lack of reporting of any two of these elements.
Very serious risk of bias was indicated by poor, or lack of
reporting of, more than one of the elements of study validity.
Selective outcome reporting is also an important element of
study validity, but was omitted from this assessment as it is
difficult to assess and would result in almost all validity
assessments suggesting serious risk of bias. In observational
studies confounding and similarity of the different groups at
baseline needed to be assessed.
N Imprecision – serious imprecision was assumed to occur when
the review collated ,300 total events (dichotomous outcomes)
or a total population size ,400 (continuous outcomes). Very
serious imprecision occurred when there were ,100 total
events or a population size of ,150 or where these were not
reported and could not be estimated. Where the events or
population were not reported, but the effect was statistically
significant the evidence were assessed as at serious risk of bias.
Where the number of events was not provided for dichoto-
mous outcomes then we assumed that imprecision was serious
(rather than very serious) if the review stated that there were at
least 1000 participants.
N Inconsistency – Unexplained heterogeneity of results. Scored
‘‘no’’ where heterogeneity was not present, or where it was
present but explored, and scored ‘‘serious’’ where heterogene-
ity was clearly present (stated by the reviewers or clearly
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observable in the forest plot) but not explored or explained, or
where not reported, or where only 1 study was found (as
homogeneity could not be corroborated).
N Indirectness of evidence – presence of an indirect comparison
or indirect evidence (studies did not directly address the
question). Where intermediate markers such as entomological
parameters were measured rather than health outcomes such
as actual cases of disease or disease side effects such as low
serum haemoglobin and miscarriage (side effects of malaria),
this was considered indirect evidence (scored as serious risk of
indirectness of evidence).
N Publication bias was assessed as ‘‘undetected’’ (score 0) or
‘‘strongly suspected’’ (score 21) on the basis that it was
assessed and no evidence of bias was found. Where no
information was presented this was scored ‘‘strongly suspect-
ed’’ unless there were fewer than 10 included studies as
publication bias is difficult to assess in the presence of so few
studies.
The GRADE summary score was the addition of the previous
scores. These scores could be upgraded by the following factors: a
large effect size (RR.2 or ,0.5 score +1, RR.5 or ,0.2 score
+2), confounders working against bias (score +1), and/or presence
of a dose response (score +1).
The interpretation of these final scores were as follows: for
evidence based on intervention studies a score$0 equates to ‘‘high
quality’’, 21 ‘‘moderate quality’’, 22 ‘‘low quality’’ and #23
‘‘very low quality’’ and for evidence based on observational studies
a score $+2 equates to ‘‘high quality’’, +1 ‘‘moderate quality’’, 0
‘‘low quality’’ and #21 ‘‘very low quality’’ evidence. For more
details see Table S2.
The GRADE data were re-analysed to separate out the level of
evidence of the underlying studies from the methodological quality
of the reviews (as in the main GRADE assessment points could be
deducted where the validity of the included studies was poor, or
where the reviewer had not reported the validity of the included
studies). Where points were lost for review factors (rather than due
to underlying data) these were highlighted in red (see Table S2).
This allowed us to also calculate the maximum possible score for
the underlying evidence (assuming that the underlying studies were
of high quality but this was not reported in the reviews). This
‘‘BEST’’ GRADE score (Table S2) was the best possible grade of
the underlying studies if all un-presented study characteristics were
of very high quality (extremely unlikely). The difference between
the GRADE score and the best possible GRADE score was then
used to determine the review quality score. A score of 0 was judged
to indicate a very good systematic review, 22 #score,0 a good
review,23#score#24 a poor review and score,24 a very poor
review. This approach allowed us to directly judge the quality of
the systematic reviews independently from the underlying studies.
In addition of highlighting high quality reviews, this approach
allowed us to determine if more high quality systematic reviews are
needed to clarify the evidence (where the potential level of
evidence is reasonable, but the level of evidence as assessed from
the present reviews is not) or if further primary studies are needed
(where a really thorough review will have little or no impact on the
level of evidence we have available, and the level of evidence is not
great).
Data were summarised narratively with reference to tables on
study characteristics and GRADE assessment and individual
disease foci grouped into vector-borne diseases, waterborne
diseases, cholera and heat stress.
Results
Altogether 3176 titles and abstracts were retrieved, of which 85
were assessed for inclusion in full text and 33 systematic reviews
included (Figure 1). No suitable systematic reviews were found for
Crimean-Congo hemorrhagic fever, Chikungunya, cyanobacteria,
droughts, floods, Rift Valley fever, spotted fever rickettsioses, West
Nile or Yellow fever. Appropriate systematic reviews were found
for cholera, dengue, heat stress, leishmaniasis, Lyme disease,
malaria, tick-borne encephalitis and waterborne diseases. Table 1
describes the characteristics of all included systematic reviews.
Vector-borne diseases
24 systematic reviews concerned prevention of vector-borne
diseases (15 about malaria, 5 dengue fever, 2 leishmaniasis and one
each Lyme disease and tick-borne encephalitis). Chemoprohylaxis
(malaria 7, Lyme disease 1) and immunization (malaria 3,
leishmaniasis 1, tick-borne encephalitis 1) and vector control
measures (10, through reducing density of insect vectors, providing
barriers between susceptible humans and vectors) were common
topics for review. One review focused on culling of host species).
Environmental interventions for control of vector-borne
diseases. Environmental interventions aiming to reduce mos-
quito populations are of particular interest as their findings are
relevant to several vector-borne diseases. The reviews under this
heading relate to dengue fever, malaria and leishmaniasis.
For the five dengue reviews, the efficacy of interventions was
calculated as the ratio of entomological indices in the intervention
and control groups. There was considerable overlap in the
included studies between the five dengue reviews. The most
comprehensive review was by Erlanger et al. [41] including 56
publications covering 61 interventions. The authors identified 19
studies on chemical control of vectors. Pooled effects were only
calculated for five studies that used outdoor adulticiding and
reported their results as Breteau Index (BI) (number of containers
with Aedes spp. larvae per 100 houses). Ten studies assessed
biological control, of which 9 were included in a pooled analysis.
The one study not included showed increased dengue risk in the
intervention arm. GRADE suggested low to very low quality
evidence for both chemical and biological interventions, and
scores were low partly because study validity was not reported and
heterogeneity was not explored or explained in the reviews (such
reporting may have raised the score, or may not if the validity of
included studies was low).
The review included 14 environmental management interven-
tions such as removing unused water containers and covering used
ones and the authors conducted three pooled analyses according
to the outcome measure with: 9 interventions reporting BI, 10
interventions reporting container index (CI) and 10 studies
reporting house index (HI). Finally, this review included 18
integrated interventions, 13 combined environmental with chem-
ical and 5 environmental with biological. The authors reported
pooled effect analyses of combined interventions for all three
entomological indices. GRADE suggested that the quality of
evidence for integrated vector management was very low. Scores
for each of the five GRADE criteria are detailed in Table S2.
Erlanger et al. [41] concluded that dengue vector control is
effective in reducing vector populations. However, as indicated by
GRADE scores, such a conclusion is not supported by the quality
of evidence. The main problem is that no consideration was given
to study quality or design and the impact of this on pooled effect
size. The authors did assess publication bias, and found evidence
of it for some analyses, but no attempt was made to adjust the
pooled effects. The authors investigated the sources of heteroge-
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neity but only through subgroup analysis for intervention type.
Finally, because pooled analyses excluded some studies, the
authors did not attempt to investigate if this would bias their
conclusions. As entomological parameters (which may or may not
relate strongly to health) were assessed, the outcomes were
considered to be indirect, which also reduced the validity of the
evidence.
Esu et al. [42] focussed on effectiveness of peridomestic
insecticide spraying. They included 15 studies some of which
were included in earlier reviews. The authors found that many
studies were of poor quality and few took account of possible
confounders. This is in accordance with GRADE which suggested
very low quality evidence. No meta-analysis was reported,
presumably because of the poor comparability of studies. In a
narrative analysis the authors concluded that the evidence for any
value of peridomestic space spraying was weak as only some
studies showed an effect, which was not sustained, with mosquito
populations returning to the same level or higher within few weeks.
Heintze et al. [43] focussed on community-based control
programmes and included 11 studies. The authors found that
most studies were of low quality and concluded that the evidence
of the effectiveness of community-based dengue control pro-
grammes is weak, which was supported by GRADE summary
score. Ballenger-Browning and Elder focussed on ‘‘multi-modal’’
mosquito reduction interventions (integrating more than one type
of intervention) [44]. They identified 21 studies of which three
were cluster randomised controlled trials (cluster RCTs), two were
RCTs, three were interrupted time series and 13 were non-
randomised controlled trials. The effect of five studies of
behavioural interventions, 5 of biological interventions and 6 of
chemical interventions was investigated. Many studies were also
included in Erlanger et al. [41]. However, the authors did not
present a meta-analysis and concluded that little evidence exists to
support the efficacy of mosquito abatement programs [44], in
accordance with GRADE score.
Al-Muhandis and Hunter focused on the role of community
education interventions [45]. They included 22 studies and
reported a pooled relative effectiveness of 0.25 (95%CI 0.17–
0.37). The authors reported substantial heterogeneity but no
significant publication bias, and investigated causes of heteroge-
neity using multi-level modelling. They found that 61% of
heterogeneity could be explained by two variables (whether
contemporary or historic controls were used and the time from
intervention to assessment). Studies using historic controls
substantially over-estimated intervention effectiveness compared
to studies using concurrent control groups. When restricted to
those studies with contemporary controls, educational interven-
tions still appeared to be effective, but effectiveness declined after
18 months. There was no additional value of combining
educational with chemical or biological interventions. GRADE
suggested very low quality evidence.
Most reviews of dengue fever were considered of poor quality,
this suggests that before further trials are commissioned in this
area, high quality systematic reviews of the evidence are required.
For malaria Keiser et al. reviewed environmental measures
aimed at reducing disease transmission [46]. They identified 40
studies, of these, 27 assessed effects of environmental modification
such as drainage, filling-in ponds and pools and river boundary
modification. Four studies assessed effects of environmental
manipulation (e.g. intermittent irrigation) and 9 modification or
manipulation of human habitation (e.g. mosquito proofing homes).
The reviewers reported significant heterogeneity and evidence of
publication bias but presented the results of meta-analyses and
concluded ‘‘malaria control programmes that emphasise environ-
mental management are highly effective in reducing morbidity
and mortality’’. The authors took little account of study quality,
stating that it was impossible to scrutinise the methodological
Figure 1. Flow diagram describing paper selection and inclusion/exclusion process according to PRISMA guidelines.
doi:10.1371/journal.pone.0062041.g001
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quality as most studies were implemented 50–100 years ago.
GRADE assessment suggested the quality of evidence was
moderate for environmental manipulation and very low for the
other intervention types, methodological issues included use of
historical controls (before-after studies) in many studies and not
accounting for possible confounding factors (additional treatments
or personal protection interventions). The authors’ conclusion that
environmental management is highly effective in reducing
morbidity and mortality is not substantiated by the evidence. A
further high quality review of the evidence would be helpful before
commissioning further primary research in this area.
One systematic review addressed the control of visceral
leishmaniasis [47] and identified 14 intervention studies, 5 of
which concerned culling seropositive dogs, 4 insecticide use, 4
combined culling and insecticides and one vaccinating dogs.
Outcome measures varied, including both canine and human
infection rates, making meta-analysis difficult. The authors
adequately considered the studies strengths and limitations,
concluding there was no strong evidence for a significant impact
of any of the interventions reviewed, concurring with the GRADE
assessment of very low quality evidence. Additionally, good quality
reviews are needed.
Personal protective measures for control of vector-borne
diseases. Personal protection measures include use of bed nets,
mosquito coils, immunization and pharmacological prophylaxis.
Three reviews considered the effectiveness of insecticide-impreg-
nated bed nets to control malaria. Choi et al. identified 22 field
trials of which 6 were included in a meta-analysis comparing
malarial infection in people using permethrin-impregnated bed
nets versus untreated bed nets, and 6 versus no bed nets [48].
Studies were omitted from meta-analysis for poor study design,
possible confounding or different outcome measures. Permethrin-
impregnated bed nets compared to untreated bed nets reduced the
risk of parasitaemia (RR 0.76, 95%CI 0.62 to 0.94), while
permethrin-impregnated nets compared to no bed nets reduced
the risk further (RR 0.49, 95%CI 0.42 to 0.60). The level of
evidence as assessed by GRADE was of very low quality as validity
of included studies was assessed but not reported, heterogeneity
apparent in forest plots was not reported or discussed and
publication bias was not reported.
More recent systematic reviews of bed net use have focussed on
pregnant women and children. Gamble et al. reported on low
birth weight, miscarriages and stillbirths and placental parasitae-
mia and found consistent protective effects of RCTs of bed nets
[49]. As the included studies were assessed for validity, showed
little heterogeneity of effect and included large numbers of
participants, GRADE suggested moderate to very low quality
evidence. Eisele et al. included cluster RCTs assessing effects of
insecticide-treated mosquito nets on childhood mortality (3 RCTs),
incidence of uncomplicated malaria (4 RCTs) and prevalence of
malarial parasitaemia (6 RCTs) [50]. Use of insecticide-treated
bed nets was associated with health gains in all three outcomes but
as the validity of the included RCTs was not assessed, the GRADE
level of evidence was of very low quality. Eisele at al. meta-
analysed 7 before-after studies for indoor residual spraying on all-
cause childhood mortality (3 studies), incidence of uncomplicated
malaria (3 studies) and prevalence of malarial parasitaemia (5
studies) [50]. As reported by the reviewers, the evidence had
serious limitations and was of very low to moderate quality. Their
review was considered of good quality, therefore, the level of
evidence can only be improved by conducting new trials.
Lawrence and Croft included 15 controlled trials of mosquito
coils, using a variety of outcomes [51]. As they found no clinical
malaria outcomes, they concluded that there was no evidence that
burning mosquito coils prevents malaria acquisition, but they
reported that such coils inhibit nuisance biting. The quality of
evidence was very low.
Immunization for vector-borne diseases. Three Co-
chrane reviews by Graves and Gelband assessed vaccination for
malaria. One review including 10 RCTs and quasi-RCTs of SPf66
vaccine (against the blood (asexual) stage of the malaria parasite)
concluded that SPf66 was not protective against new malarial
episodes of P. falciparum in Africa (RR 0.98, 95% CI 0.90 to 1.07)
but modestly protective in South America (RR 0.72, 95% CI 0.63
to 0.82) [52]. GRADE showed high quality evidence. One review
included five trials of MSP/RESA vaccine (also against parasitic
blood stages), which showed promise (RR of new malarial episodes
0.38, 95% CI 0.26 to 0.57) but the results were difficult to interpret
due to small numbers of new malarial episodes and lack of
statistically significant effects [53]. One review of nine trials of
vaccines targeted at the sporozoite or liver stages (CS-NANP,
CS102, ME-TRAP and RTS, S) found that only (RTS, S) reduced
clinical episodes of malaria by 26% (95% CI 13% to 37%) in semi-
immune children for up to 18 months [54]. The quality of
evidence was moderate to high. The protective effect was reduced
in adults, and RTS, S was less efficient in preventing new malaria
infections in children and adults, 6% and 4%, respectively with
moderate quality evidence. The high quality reviews in this area
suggest that where evidence is unclear or of low quality further
trials are required to address relevant questions.
Demicheli et al. reviewed tick-borne encephalitis vaccine [55] in
a Cochrane collaboration review including 11 trials. They
concluded that the vaccine was highly immunogenic but that the
relationship between seroconversion and clinical protection is not
clear. The quality of evidence was very low as the review included
trials with unclear allocation concealment and without blinding,
found high levels of heterogeneity and no study reported a tick-
borne encephalitis case. Further trials are needed to address this
issue.
Chemoprophylaxis for vector-borne diseases. Eight re-
views addressed the value of pharmacological interventions for the
prevention of vector-borne diseases, one for Lyme disease and the
rest for malaria. The Lyme disease review included four placebo-
controlled RCTs of post-exposure prophylaxis using penicillin,
amoxicillin, tetracycline or doxycycline [56]. The authors found a
significant reduction in the odds of developing Lyme disease (OR
0.084, 95% CI 0.002 to 0.57), but the evidence was of very low
quality as there were only 13 cases of Lyme disease. Therefore,
further trials are needed.
Amongst seven Malaria reviews, one was superseded by others
and will not be discussed [57]. Three reviews assessed the
effectiveness of specific prophylactic agents for malaria: prima-
quine [58], mefloquine [59] and atovaquone-proguanil [60], all
finding that the prophylactic agent was highly effective at reducing
malaria risk. The quality of evidence was very low for primaquine
as validity of the included controlled studies was not assessed and
heterogeneity apparent in the forest plot was not mentioned or
explored [58]. The efficacy of atovaquone-proguanil in reducing
parasitaemia (RR 0.04, 95%CI 0.02–0.08) [60] was supported by
moderate quality evidence. No pooled effect size was calculated for
mefloquine because of the different study designs in the few field
trials that reported on efficacy [59]. This was supported by low
quality GRADE score.
Two reviews concerned the prevention of malaria in pregnant
women. One focussed on the impact of sulfadoxine-pyrimeth-
amine resistance in intermittent preventive therapy (IPT) [61].
The authors concluded that 2- dose IPT during pregnancy benefits
HIV-negative women in preventing placental malaria (RR 0.48,
Reducing the Health Impact of Climate Change
PLOS ONE | www.plosone.org 10 April 2013 | Volume 8 | Issue 4 | e62041
95% CI 0.35 to 0.68), low birth weight (RR 0.71, 95% CI 0.55 to
0.92), and maternal anaemia (RR 0.90, 95% CI 0.81 to 0.99). The
GRADE score was high for placental malaria prevention and
moderate for the other outcomes. Garner and Gu¨lmenezoglu
assessed effects of any preventive chemoprophylaxis or IPT drugs
vs. no drugs in pregnant women and identified 16 studies [62]
concluding that antimalarial drugs reduced severe anaemia (RR
0.62, 95%CI 0.50 to 0.78), perinatal deaths (RR 0.73; 95%CI 0.53
to 0.99) and low birth weight (RR 0.57; 95%CI 0.46–0.72).
GRADE score showed low quality of evidence.
A Cochrane review by Meremikwu et al included 11 trials of
prophylaxis with either chloroquine or pyrimethamine-dapsone
and 10 trials of IPT in children [63]. Seven trials used sulfadoxine-
pyrimethamine, one sulfadoxine-pyrimethamine and one amodia-
quone. IPT or prophylaxis was associated with fewer episodes of
clinical malaria and less severe anaemia, however, the quality of
evidence was very low and low, respectively.
Further trials are needed to improve the level of evidence of
malaria chemoprophylaxis.
Waterborne Diseases
Water interventions. Eight systematic reviews assessed the
impact of water interventions on self-reported diarrhoea
[33,64,65,66,67,68,69,70]. There was substantial overlap in
primary studies included with later reviews including more recent
studies. Most reviews focussed on household water interventions in
developing countries, including chlorination, solar disinfection and
filtration. Reviews focussing on household chlorination [64],
assessing effects on diarrhoea and clinical cholera [68] and
observational studies linking self-reported diarrhoeal disease to
distance from home to water source [33], suggested pooled
reductions in diarrhoeal disease of 30 to 50% or pooled Relative
Risk or Odds Ratios of 0.5 to 0.7 for household interventions, but
the GRADE quality of evidence was very low. The main issues are
use of self-reported diarrhoea in unblinded intervention trials,
significant heterogeneity in effect sizes and evidence of publication
bias. Whilst most authors commented on heterogeneity, only two
sought to investigate heterogeneity sources [69,70]. Waddington
used subgroup analyses, whereas Hunter used meta-regression.
Hunter found that whether or not the study was blinded,
intervention type, duration of follow-up and whether or not the
intervention was conducted in an emergency setting explained
90% of the heterogeneity [69]. He concluded that most household
water treatment interventions have little or no public health value
and that their apparent effectiveness is due to poor study design
(lack of blinding and very short follow-up periods). He suggested
that ceramic filters were more effective than other technologies,
but quality of evidence was very low.
Two reviews reported on community water supply interventions
and found that their impact was weak [66,70]. No conclusions
about the value of community water interventions can be made in
developing country settings. A review investigating the relationship
between distance to fetch water and self-reported diarrhoea found
an association between increased distance and increased risk [33],
but this is not definitive due to poor quality studies as reflected by
very low quality of evidence. In this area further high quality
reviews are needed before further trials are commissioned.
Immunization for waterborne diseases. One review
considered the value of injected whole cell or subunit vaccines in
cholera prevention [71]. The authors found 16 trials involving
over 1 million participants, reporting reduced risk of death from
cholera (RR 0.49, 95%CI 0.25 to 0.93) and reduced risk of
contracting cholera at 12 months for children ,5 years old (RR
0.52, 95%CI 0.42 to 0.65). The evidence was of moderate quality.
The authors concluded that injected cholera vaccines are safe and
more effective than generally realised but that injected vaccines
have been superseded by oral ones.
Heat stress
Two reviews related to heat stress were found. A review of the
impact of green spaces within cities found ,1uC lower temper-
atures in city parks than in built up city areas [72]. The GRADE
score showed very low quality of evidence. Whether such green
spaces had any impact on reducing morbidity and mortality
during heat waves was not addressed. The second review included
14 observational studies investigating whether heat health warning
systems increased awareness and reduced mortality and morbidity
[73]. The authors presented a narrative synthesis and did not
judge study validity. They reported high levels of awareness about
the public health campaigns and heat wave events amongst the
general public, but evidence of behavioural change as a result of
this awareness was less forthcoming. The associated quality of
evidence was considered to be of very low quality. A key problem
was that some studies recruited people in the street and so did not
include the group particularly vulnerable to heat stress. Most of
the studies made comparisons between different heat wave periods
in the same city before and after the heat health warning system
was in place. Generally they found reduced mortality in the second
period, which was attributed to the public health response.
However, as pointed out by the authors, few studies considered
other possible factors that may have had an impact. For example
in Chicago, there had been a failure in the electricity supply during
the first heat wave which would have exacerbated the adverse
impact. In addition, harvesting or mortality displacement is an
important factor that is likely to be a major contributor to the
reduced mortality associated with the second heat wave, but this
has not been considered. Bassil and Cole concluded that limited
evidence suggests a positive impact of public health interventions
for heat waves but the most vulnerable groups are not being
adequately reached [73]. Further primary research is needed to
address effective interventions for heat stress.
Discussion
In this study, we aimed to identify high priority climate sensitive
health threats that are likely to be exacerbated in a warmer world.
We are aware that health impacts of climate change are highly
dependent on location, economical status, infrastructure, health
services (to name just a few). The main climate sensitive diseases
are West Nile fever, dengue fever, Chikungunya fever, malaria,
leishmaniasis, tick-borne encephalitis, Lyme borreliosis, Crimean-
Congo haemorrhagic fever, spotted fever rickettsioses, Yellow
fever, Rift Valley fever, cholera, waterborne diseases, floods,
droughts, cyanobacteria, and heat stress. Subsequently, we looked
for any intervention that is directed against these diseases with any
health related outcome measure.
Interventions for vector-borne diseases
Immunization and chemoprophylaxis have the strongest
evidence for prevention of vector-borne diseases, however, these
are limited to single infections. Although insecticide-impregnated
bed nets are effective, their action is limited to night flying
mosquitoes and can be less efficient for dengue fever and
Chikungunya vectors. Immunization programmes are a long
way away for these diseases, especially dengue fever, because of
concerns that immunization may increase the risk of dengue
haemorrhagic fever [74]. Consequently, control of these diseases
will rest largely on vector control strategies.
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Most systematic reviews for control of vector-borne diseases
focused on the effect of environmental interventions on entomo-
logical indicators. Undeniably, vector presence and survival is key
in disease transmission, however, reduction of mosquito popula-
tions does not necessarily translate in decreased disease risk. In
fact, several such papers have been downgraded using GRADE for
indirectness as they were not assessing health outcomes. Our
recommendation is that future studies of the effect of environ-
mental interventions for the control of vector-borne diseases
should be of acceptable duration and should report primarily on
disease related outcome measures.
Assessment of the strength of evidence for the effectiveness of
vector control strategies depends on which review one reads. The
reviews by Keiser et al. [46] on malaria and Erlanger et al. [41] on
dengue control strongly support the effectiveness of such
interventions, in sharp contrast with other reviews. Heintze et al.
[43] concluded ‘‘Evidence that community-based dengue control
programmes alone and in combination with other control activities
can enhance the effectiveness of dengue control programmes is
weak’’. Ballenger-Browning and Elder [44] said ‘‘Little evidence
exists to support the efficacy of mosquito abatement programs
owing to poor study designs and lack of congruent entomologic
indices’’ and Esu et al. [42] stated ‘‘Based on a comprehensive
search of available peer reviewed literature, the effectiveness of
peridomestic space spraying in reducing dengue transmission has
not been conclusively demonstrated’’.
Why do conclusions on the strength of evidence conflict so
strongly? Principally this has to do with study quality. Although
Keiser et al. [46] and Erlanger et al. [41] mentioned study quality,
they did not account for this when drawing their conclusions.
Indeed, Keiser et al. stated that assessments of study quality were
not possible as studies were conducted over 50 years ago [46]. We
consider that problems with study design and lack of control for
confounding were obvious in these studies making them of low
quality and reducing the value of the conclusions drawn from the
meta-analyses.
Al-Muhandis and Hunter [45] used multi-level meta-regression
to assess the impact of effect modifiers. It should be stated that
such studies do not have the evidential standard of other meta-
analyses but rather of observational studies. However, 60% of the
heterogeneity in outcome measures could be explained by whether
or not studies used historic or contemporary controls and time
from intervention to assessment. In particular studies that used
historic controls (before/after studies) substantially over-estimated
effectiveness compared to studies using contemporary controls,
and the over estimation increased with time from intervention to
assessment. When analyses were restricted to studies with
contemporary controls, the impact was more modest. The use of
historic controls is considered poor practice as most historical
control groups are compromised [75,76]. Given that many studies
in Keiser et al. and Erlanger et al. were before/after studies, this
would also explain the substantial over-estimation of the value of
such interventions [41,46].
Interventions for waterborne diseases
The impact of climate change on waterborne diseases in
wealthy countries, relying on well-maintained water treatment
plants, is likely to be negligible. The disease burden will fall largely
on those reliant on small systems with inadequate treatment and
intermittent supply, for which household water treatment could be
an important public health intervention for adaptation to climate
change. However, evidence in favour of such interventions is weak
and divergent between studies. Hunter suggests that household
water filtration with ceramic filters has a sustainable public health
value [69]. However, this observation springs from meta-
regression and so carries the weight of an observational study.
For firm conclusions to be drawn there is a need for properly
conducted double blinded trials on water filters. Evidence of
reduction of diarrhoeal diseases after household water interven-
tions was mainly derived from non-blinded interventions. Schmidt
and Cairncross reported that when analyses were restricted to
blinded studies no effect was demonstrable [77]. They suggested
that the apparent beneficial effect was due to ‘‘courtesy bias’’
where people who received the intervention were less likely to
report illness. The value (or otherwise) of household water
treatment is still a topic of considerable debate. The evidence
does support household water treatment for the prevention of
cholera, though this was based on only three studies [68].
Explanations for the lack of effectiveness of some interventions in
developing countries have been discussed previously [78]. Part of
the problem is that chlorination alone is not effective against
Cryptosporidium and has reduced impact against Giardia (two
particularly important waterborne pathogens). A study of small
systems in France showed that chlorination alone did not remove
risk of illness associated with contaminated supplies, even when
indicator organisms were inactivated [79]. However, the main
problem appears to be inconsistent use. Arnold and Colford
showed that the use of SODIS (a solar disinfection system) declines
quickly after a campaign [64]. Furthermore, Hunter et al. showed
that even occasional days when people revert to drinking
untreated water are sufficient to undermine most of the public
health gains [80].
Interventions for Heat stress
We found one systematic review concerned with the effect of
green spaces on air temperature and reported a slight cooling
effect. However, the public health implication of such intervention
is not clear. Nevertheless, this kind of intervention may have
several co-benefits. Greening a city for example can improve air
quality, promote physical activity, protect against sunlight
exposure, enhance storm water management and increase
property values, which are not all health related and certainly
could not be accounted for using GRADE method.
The main public health intervention for Heat stress is heat
health action plans. Bassil and Cole suggested that particularly
vulnerable sub-groups were inadequately reached by heat health
action plans [73]. A meta-analysis of observational studies seeking
to identify factors associated with increased disease risk from heat
waves allowed to identify this group: elderly people who are
unable to care for themselves and are house-bound and/or with
pre-existing medical conditions such as psychiatric, cardiovascular
and pulmonary illness [81]. Abrahamson et al. interviewed 73
elderly men and women (.72 years old) living at home in London
and Norwich about their perceptions of the risks from excessive
heat and found that the majority were aware of the dangers of a
heat wave in others, but did not think that they themselves are at
risk (despite some of them suffering from relevant chronic diseases)
[82]. Bassil and Cole concluded there is a high level of heat risk
awareness, but this does not necessarily translate into behavioural
change because of faulty self-perception of vulnerability [73].
Despite no strong evidence supporting public information ahead
of heat waves reducing mortality, the costs of such public health
interventions are almost negligible and so we would argue that
public alerts still form part of the response to heat wave. However,
the issue remains as to how the most vulnerable can be reached.
Clearly public alert announcements cannot be the sole public
health strategy and research needs to be targeted at protecting the
vulnerable group.
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For each intervention type, we assessed the quality of evidence
using the GRADE system, based on five criteria (risk of bias,
imprecision, inconsistency, indirectness of evidence and publica-
tion bias) each individually assessed, to come up with an overall
GRADE score. This quality assessment should allow an objective
judgement of the validity of the conclusions reached by the authors
of the systematic reviews. While GRADE assessment is widely
used by international organisations and in peer-reviewed litera-
ture, it only accepts RCTs as high quality evidence. As Guyatt
et al. state ‘‘Those applying GRADE to questions about diagnostic
tests, to public health, or to health systems questions will face some
special challenges’’ [39]. Nevertheless, despite this concern, Guyatt
et al. state ‘‘The GRADE system can, however, also be applied to
public health …’’. Since the majority of the public health
interventions assessed in this study were of environmental nature
and cannot be randomised, GRADE assigned them as low quality
evidence. We tried to counterbalance this limitation by adopting a
slightly different scaling system for intervention and observational
studies. In any event, the use of the GRADE approach is still a key
recommendation of WHO policy formulation. This is particularly
relevant considering that one key aspect of climate policy is the
concept of co-benefits, when an intervention yields multiple
benefits which may or may not be included in the main outcome
measures. GRADE does not allow us to account for such full
benefits evaluation. Nevertheless it should still be used as a part of
multi-level grading system for quality of evidence and strength of
recommendations. Nevertheless, the limitation of the GRADE
system should be considered especially when evaluating different
types of public health interventions as we did here.
In addition, we found that the systematic reviews we included
differed in quality from one to another. Consequently a low
GRADE score could indicate a good quality review of poor quality
primary studies or a poor quality review of studies of uncertain
quality. In order to assess this we created a scoring system to grade
the quality of a review independently of the quality of the
underlying studies. This we called the review quality score, which
was the difference in GRADE score and the best possible GRADE
score assuming that all un-presented study characteristics were
indicative of high quality evidence. It should be stated very clearly
that evidence from a systematic review with a poor calculated
GRADE score and excellent quality Best GRADE score is still
poor quality evidence and should not be used to influence practice
without further consideration. What this approach does do is help
identify those areas with low quality of evidence within published
systematic reviews that may benefit from a more thorough
analysis.
In this study, we attempted to systematically review and assess
the quality of evidence of public health interventions to reduce the
burden of climate sensitive diseases. One of the main findings was
that for several diseases, most or all of the primary studies were
undertaken in the developing word. This was particularly the case
for vector-borne diseases where currently the major burden falls in
tropical and sub-tropical countries. Undeniably, access to
resources is an important determinant of climate change
adaptation and so one should be very careful when extrapolating
public health research from developing to developed countries and
vice-versa. However, this is not a reason for ignoring the lessons
for the developed world from research conducted in developing
countries, especially when research in the developed world is weak.
Synthesis
As discussed above, the World Health Organization has called
for systematic reviews on the value of public health measures
aimed at reducing the impact and public health effects of climate
change [9]. In this systematic review of systematic reviews, we
have shown that several systematic reviews already exist for some
diseases likely to be more of a threat in a warmer world, while for
others there are none. The areas with the most pressing need for
evidence are in the management of drought, floods, air pollution
and food safety. The likely reason for this is the scarcity of primary
studies as indeed was identified in our first screen (table S1). This
result is not perhaps surprising. By their nature, drought and flood
events are difficult to predict and when they occur most agencies
are concerned primarily with responding rather than conducting
research. Nevertheless, if we are to improve our ability to manage
them, then we need to consider how best to improve the quality of
the evidence base. This may require the development of groups of
researchers able to get funding and ethical clearance very rapidly
following extreme events.
A particular concern is that systematic reviews including
overlapping studies have come to very different conclusions.
Examples include the systematic reviews on water quality and
diarrhoeal disease and also the reviews on the impact of dengue
control on entomological indices. Despite the wide availability of
guidance documentation on how to conduct systematic reviews, it
is of great concern that researchers can review essentially the same
primary research literature and come to starkly different conclu-
sions. It would appear that such different conclusions are drawn
partly because of the importance reviewers gave to the issue of
study quality or heterogeneity when drawing their conclusions. It
is also possible that some research synthesisers may not be as
dispassionate about the conclusions of their review as they would
have the reader believe, falling into the trap of confirmational bias.
We strongly recommend that systematic reviews in this area
should report fully on the validity of the included studies (whether
interventional or observational), assess and examine heterogeneity
and publication bias, report on health outcomes and state numbers
of health events as well as population size. This will allow readers
to truly understand the strength of evidence presented. Addition-
ally systematic reviews and meta-analyses should include explicit
GRADE scoring by an independent scorer to reflect the quality of
evidence, especially when assessing effectiveness of public health
interventions. This would be valuable for informing stakeholders
and policy makers and should assist future policy options for
climate change adaptation.
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